Raphael Pharmaceutical announced the resignations of Ajay Kumar Dhadha as Chairman and Director and Guy Ofir as CFO, General Counsel and Director, and the appointment of Uri Tadelis as Chief Financial Officer.
| IndividualAjay Kumar DhadhaGuy OfirUri Tadelis | RoleChairman of the Board; DirectorChief Financial Officer; General Counsel; DirectorChief Financial Officer | Type of ChangeResignedResignedAppointed | Effective DateJune 30, 2026July 16, 2026July 16, 2026 | ReasonResignation; not due to disagreement with the CompanyResignation; not due to disagreement with the CompanyNot disclosed | Replacement InfoNot disclosedUri Tadelis appointed CFON/A | Background DetailsNot disclosedNot disclosedNot disclosed | Board/Committee Role ChangesNot disclosedNot disclosedNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.